Evidence map›Paper›PMID 33920597›Full record

ReviewMolecules (Basel, Switzerland)2021

Recent Advances in the Use of the Dimerization Strategy as a Means to Increase the Biological Potential of Natural or Synthetic Molecules.

Alexis Paquin, Carlos Reyes-Moreno, Gervais Bérubé

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Strategic re-engineering of antibiotics.Nature reviews bioengineering · 2025
    Article
  6. Article
  7. Unexpected Intermolecular C-H···O Hydrogen Bonds andThe journal of physical chemistry. B · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexis PaquinDepartment of Chemistry-Biochemistry and Physics, University of Québec at Trois-Rivières, C.P. 500, Trois-Rivières, QC G9A 5H7, Canada.
Carlos Reyes-MorenoGroupe de Recherche en Signalisation Cellulaire, University of Québec at Trois-Rivières, C.P. 500, Trois-Rivières, QC G9A 5H7, Canada.
Gervais BérubéDepartment of Chemistry-Biochemistry and Physics, University of Québec at Trois-Rivières, C.P. 500, Trois-Rivières, QC G9A 5H7, Canada.

Funding

Aligo Innovation 150923Cancer Research Society 22471CIHR 392334Ministère de l'Économie et de l'Innovation N/A
6 · The paper itself

Abstract

The design of

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBiological ProductsDimerizationHumansNucleosidesSteroidsStructure-Activity RelationshipTerpenesAnti-Bacterial AgentsAntineoplastic AgentsBiological ProductsNucleosidesSteroidsTerpenesantitumor agentsbiological activityC2-symmetrydimersdrug designsynthesis

Identifiers

PMID33920597
PMCPMC8073093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.